About us

abc biopply is specialised in the standardisation of biological components and complex cellular systems. With 3D CoSeedis™, it is at the cutting edge of 3D cell culture technologies and defines a quantum leap in 3-dimensional ex vivo cell biology.

abc biopply is an innovative and dynamic biotech company headquartered in Solothurn with laboratory and research facilities in Cham, Switzerland.

The company was founded in 2018 with the aim to substantially improve the level of standardisation of complex cell biological processes, namely in the area of 3-dimensional cell culture technologies.

abc biopply devotes its know-how and expertise in complex cell culture technologies to define and validate standardised workflows, technologies and protocols, particularly in 3-dimensional applications.

Important Milestones

abc biopply ag – The leading Swiss expert in Biostandardisation

  • 2018 foundation of the company abc biopply in Solothurn.
  • 2018 acquisition of the unique translational technology platform 3D CoSeedisTM for applied and standardised cancer research and diagnostics.
  • 2018 Opening production development and training center
  • 2018 Validating portfolio as cell systems solution provider for Basic Research
  • 2019 Early access of first generation 3D CoSeedis™
  • 2019 Sign distribution contracts for CH/EU and Canada
  • 2019 Proof of Concept of 3D CoSeedis™ HCS/HTS workflos
  • 2019/2020 Letter of Intent with strategic partners in HTS/HCS
  • 2020 Proof of Concept of 3D CoSeedis™ IHC/IF applications

Value Propositon by workflow driven standardisation of complex cell culture processes

Adding value by time/cost saving via:

  • Standardised and validated protocols
  • Increased efficiency through highly reproducible 3D cell constructs
  • Intuitive and validated HTS/HCS-compatible read-outs
  • Versatile applicability through modular set-up

 

Team

 

Events

Contact us